Clinical Trial Update: The Effects of Intraoperative Esketamine on Postoperative Pain and Mood in Patients With Inflammatory Bowel Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the effects of intraoperative esketamine on postoperative pain and mood in patients with Crohn's disease and depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Major Depressive Disorder

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Crohn Disease, Depression | Phase 4 | Status: COMPLETED